BioNTech SE (BNTX)

BioNTech SE (BNTX) is a healthcare company (biotechnology) based in Germany. The share price is $85.24, down 0.03% on the day, which values the company at $21.13B. Price as of 17 Nov 2026, 18:23 UTC, from Yahoo Finance.

Key facts

Share price
$85.24−0.03% today
Market value
$21.13B
Funk Score
25/100
200-week average
$103.2917% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

BioNTech SE in more detail

BNTX trades at -16.1× next year's expected earnings, 8.7× sales. It sits 17% below its 200-week average of $103.29.

Its Funk Score is 25 out of 100 (financial strength 4.8, profitability 1.0, growth 1.7, each out of 10).

In its favour: More cash than debt. Worth checking: Thin interest cover.

4 of the superinvestors tracked here hold BNTX, including Temasek (0.3% of the portfolio), Primecap team (0.2% of the portfolio), Dodge & Cox team (0.2% of the portfolio).

Superinvestors holding BNTX

4 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:BNTX vs GH (BioNTech SE vs Guardant Health)BNTX vs THC (BioNTech SE vs Tenet Healthcare)BNTX vs ALNY (BioNTech SE vs Alnylam Pharmaceuticals)BNTX vs VTRS (BioNTech SE vs Viatris)BNTX vs ZBH (BioNTech SE vs Zimmer Biomet Holdings)

All health care companies by market valueLargest companies in GermanyAll stocks A–Z

BioNTech SE (BNTX): questions and answers

What is BNTX's PEG ratio?

BioNTech SE's PEG ratio is 0.05 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is BioNTech SE's market cap?

BioNTech SE is valued at $21.13B at a share price of $85.24.

Is BNTX above its 200-week moving average?

No. BNTX is 17.5% below its 200-week average of $103.29. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is BioNTech SE growing?

Over the last three fiscal years BioNTech SE's revenue grew -45.1% a year.

Does BNTX pay a dividend?

BioNTech SE does not currently pay a regular dividend.

Which famous investors own BNTX?

In their latest quarterly filings, Temasek (0.3% of the portfolio), Primecap team (0.2% of the portfolio), Dodge & Cox team (0.2% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold BNTX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “BioNTech SE (BNTX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BNTX

Underlying data: Yahoo Finance; company filings with the SEC.